| Lead Manager/ | # of | Price Range | Dollar | SCOOP | ||
| New Filings (Proposed Symbol) | Joint-Lead Managers | Shares | Low | High | Volume | Ratings |
| Adaptimmune Therapeutics PLC (ADAP) | BofA Merrill Lynch/ Cowen and Company/ Leerink Partners | $150.00 | n.a. | |||
| aTYR PHARMA (LIFE) | J.P. Morgan/ Citigroup | $86.25 | n.a. | |||
| Avondale Acquisition (AACOU) | Maxim Group/ Ladenburg Thalmann | 20.00 | $10.00 | $10.00 | $200.00 | n.a. |
| Bojangles (BOJA) | BofA Merrill Lynch/ Wells Fargo Securities/ Jefferies | $100.00 | n.a. | |||
| Fenix Parts (FENX) | BMO Capital Markets/ Stifel | $100.00 | n.a. | |||
| PGA Holdings (TBA) | Barclays/ Goldman Sachs/ William Blair | $100.00 | n.a. | |||
| n.a. (not available) | ||||||
| Postponed | ||||||
| ViewRay (VRAY) | Cowen and Company/ Stifel | 4.00 | $12.00 | $14.00 | $52.00 | 1-Star |
| Withdrawn | ||||||
| None | ||||||
| New Terms | ||||||
| Aduro Biotech (ADRO) | BofA Merrill Lynch/ Leerink Partners | 5.00 | $14.00 | $16.00 | $75.00 | 3-Stars |
| BiondVax Pharmaceuticals Ltd. (BVXV) | Aegis Capital Corp | 1.40 | $6.68 | $6.68 | $9.35 | N/C |
| Carbylan Therapeutics (CBYL) | Leerink Partners | 12.00 | $5.00 | $5.00 | $60.00 | 1-Star |
| Cidara Therapeutics (CDTX) | Jefferies/ Leerink Partners | 4.00 | $14.00 | $16.00 | $60.00 | 1-Star |
| OpGen (OPGN) | Maxim Group | 3.75 | $8.00 | $10.00 | $33.75 | n.a. |
| Party City Holdco (PRTY) | Goldman Sachs/ BofA Merrill Lynch | 21.88 | $15.00 | $17.00 | $350.00 | 2-Stars |
| Viking Therapeutics (VKTX) | Laidlaw & Company (UK) Ltd. | 2.50 | $7.00 | $9.00 | $20.00 | 1-Star |
| Virtu Financial (VIRT) | Goldman Sachs/ J.P. Morgan/ Sandler O’Neill + Partners, L.P. | 16.53 | $17.00 | $19.00 | $297.58 | 2-Stars |
| N/C = No Call – stock traded on the on Tel Aviv Stock Exchange under the symbol “BNDX” | ||||||
| IPOs Priced | Lead | Shares | Amount | Offer | Close | % |
| Week of April 6, 2015 | Manager(s) | Offered | Raised | Price | 4/10/15 | Change |
| Wowo Ltd (WOWO) | Axiom | 4.00 | $40.00 | $10.00 | $10.60 | 6.00% |
| Carbylan Therapeutics (CBYL) | Leerink Partners | 12.00 | $60.00 | $5.00 | $5.29 | 5.80% |
